MedifastFRA:MDF -4.32%68 Receivables Turnover is 0.00 as of Mar. 2026. GuruFocus rates FRA:MDF with a GF Score™ of 68/100 and a GF Value™ of €7.18 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 91 Personal Services companies, Medifast ranks worse than 1098900% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Medifast's Revenue for the
three
months ended in Mar. 2026 was €65.8 Mil. Medifast's average Accounts Receivable for the
three
months ended in Mar. 2026 was €0.0 Mil.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Medifast Receivables Turnover Related Terms
Medifast Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Medifast's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MDF vs RGS, EVTK, DROR: Receivables Turnover Comparison
For the Personal Services subindustry, Medifast's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast Receivables Turnover vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Medifast's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medifast (FRA:MDF) has a Receivables Turnover of 0.00 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Medifast and its competitors. According to the industry distribution chart, Medifast ranks #999999 out of 91 companies in the Personal Services industry.
Is Medifast's Receivables Turnover too high?
Medifast's current Receivables Turnover is 0.00. Based on the distribution chart, Medifast ranks #999999 out of 91 companies in the Personal Services industry, which is in the bottom quartile relative to peers. Overall, Medifast has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's Receivables Turnover compare to RGS and EVTK?
According to the Personal Services industry distribution chart, Medifast ranks #999999 out of 91 companies for Receivables Turnover. This places Medifast in the lower half of its industry. The industry median Receivables Turnover is 12.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Personal Services company?
The median Receivables Turnover among Personal Services companies is 12.86, based on 91 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Medifast and its competitors. For the Personal Services industry, the median Receivables Turnover is 12.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medifast's current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (FRA:MDF) is currently considered Modestly Overvalued. The stock's GF Value™ is €7.18, compared to a current price of €9.08 — trading 26.5% above its estimated fair value. The current Receivables Turnover is 0.00. Medifast's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Medifast (FRA:MDF), the current Receivables Turnover is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medifast (FRA:MDF) Overvalued in 2026?
Based on GuruFocus' analysis, Medifast stock appears to be overvalued.
The current stock price of €9.08 is trading 26.5% above its estimated GF Value™ of €7.18.
GuruFocus considers Medifast to be Modestly Overvalued.
Key valuation signals for FRA:MDF:
Receivables Turnover: 0.00
GF Value™: €7.18 vs. price of €9.08 (26.5% above fair value)
No single metric tells the full story. See the FRA:MDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
68GF Score
Get the complete analysis for FRA:MDF
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MDF has been successfully added to your 
